<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>faffd212-9a7b-4314-9d98-be4d961934b1</id>
  <name>Anti_Infective Agents_Complicated Infections Pediatric Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~faffd212-9a7b-4314-9d98-be4d961934b1~NAME~Anti_Infective Agents_Complicated Infections Pediatric Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Choose ONE antibiotic option for treatment of Complicated Appendicitis/Non-operative Management of Late Perforated Appendicitis with Phlegmonous Mass or Abscess&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;cefTRIAXone and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;cefTRIAXone recommended dosage is 50 to 75 mg/kg/dose daily&lt;br&gt;metroNIDAZOLE recommended dosage is 40 mg/kg/day divided q12h&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;cefTRIAXone and metroNIDAZOLE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;cefTRIAXone injection; 50 mg/kg/dose, intravenous, every 24 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;cefTRIAXone and metroNIDAZOLE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;metroNIDAZOLE injection; 40 mg/kg/day, Intravenous, every 12 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;ampicillin recommended dosage is 200 mg/kg/day divided q6h&lt;br&gt;gentamicin recommended dosage is 2.5 mg/kg/dose&amp;nbsp;&lt;br&gt;metroNIDAZOLE recommended dosage is 40 mg/kg/day divided q12h&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ampicillin injection; 200 mg/kg/day, intravenous, every 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;gentamicin injection; 2.5 mg/kg/dose, intravenous, every 8 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ampicillin, gentamicin, and metroNIDAZOLE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;metroNIDAZOLE injection; 40 mg/kg/day, intravenous, every 12 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 2: piperacillin/tazobactam - Reserved for patients with signs and symptoms of severe sepsis&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Dosed as piperacillin component: &amp;nbsp;300 mg piperacillin/kg/day divided q8h&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 2: piperacillin/tazobactam - Reserved for patients with signs and symptoms of severe sepsis&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Indication?&amp;nbsp;***&lt;/p&gt;&lt;p&gt;Why is this medication preferred over a non-restricted alternative?&amp;nbsp;***&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Option 2: piperacillin/tazobactam - Reserved for patients with signs and symptoms of severe sepsis&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Anti-Infective Agents - Complicated Infections Pediatric Order Group">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Option 1: cefTRIAXone and metroNIDAZOLE OR ampicillin, gentamicin, and metroNIDAZOLE">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="cefTRIAXone and metroNIDAZOLE">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 50 mg/kg/dose, intravenous, every 24 hours"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="646c8a3d-efb3-4d4e-889a-0b5b5b614ee8" concept_name="PHARM metroNIDAZOLE injection Order" max="1" path="/items" name="metroNIDAZOLE injection; 40 mg/kg/day, Intravenous, every 12 hours"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="ampicillin, gentamicin, and metroNIDAZOLE">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 200 mg/kg/day, intravenous, every 6 hours"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c64035f-72ac-454d-bf7b-60d73c421c66" concept_name="PHARM gentamicin injection Order" max="1" path="/items" name="gentamicin injection; 2.5 mg/kg/dose, intravenous, every 8 hours"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="646c8a3d-efb3-4d4e-889a-0b5b5b614ee8" concept_name="PHARM metroNIDAZOLE injection Order" max="1" path="/items" name="metroNIDAZOLE injection; 40 mg/kg/day, intravenous, every 12 hours"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Option 2: piperacillin/tazobactam - Reserved for patients with signs and symptoms of severe sepsis">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d5b29520-ce88-4c14-a574-9546351b8f8f" concept_name="PHARM PIPERACILLIN-TAZOBACTAM IV ORDERABLE (NEO PED) [4200704] Order" max="1" path="/items" name="piperacillin-tazobactam IV (neo/ped); 300 mg/kg/day of piperacillin, intravenous, every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Option 3: clindamycin and gentamicin - for patients with ceFAZolin allergy or severe non-IgE mediated reaction to any B-lactam">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="eae3d03c-57f0-4341-8e81-0577dfab869f" concept_name="PHARM clindamycin injection Order" max="1" path="/items" name="clindamycin Injection; 40 mg/kg/day, Intravenous, every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c64035f-72ac-454d-bf7b-60d73c421c66" concept_name="PHARM gentamicin injection Order" max="1" path="/items" name="gentamicin Injection; 2.5 mg/kg/dose, Intravenous, every 8 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">
    <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>